GiroNEX – a technology spin-out from Innomech Group – has today announced a move into the pharmaceutical manufacturing equipment market with the launch of its Cube Plus automated precision powder dispensing system for use in manufacturing powder-filled capsules and vials for early phase clinical trials and related drug development studies.
The new Cube Plus system has been specifically developed to target a significant gap in the market between powder dispensing systems to help automate routine R&D laboratory ‘fill and weigh’ tasks, and high volume pharmaceutical capsule-filling machines…
29 October 2019, Cambridge, UK - Sense Biodetection Limited (Sense) has today announced that it has raised £12.3m to develop its portfolio of instrument-free, point-of-care molecular diagnostic tests, a pioneering new class of diagnostic product.
The company has raised £10.5m Series A investment co-led by Cambridge Innovation Capital (CIC) and Earlybird, with participation from Jonathan Milner and seed round investor Mercia Asset Management. Concurrent with the investment, Sense has also secured a grant of £1.8m from Innovate UK.
The company plans to invest the new funds in the development…
Cambridge, UK, October 29 2019: Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine has joined 3TR, a large-scale public-private research initiative that aims to provide new insights into the mechanisms of response and non-response to treatment within and across seven different immune-mediated diseases. Owlstone Medical will receive funds from the project to provide Breath Biopsy Collection Stations and Kits for the collection of breath samples, and analysis services for multiple studies that have been identified at this…
Cambridge, UK, and Croissy-Beaubourg, France 28th October: PredictImmune, developers of pioneering prognostic tools for guiding treatment options in immune-mediated diseases, today confirmed that it has entered into a commercial partnership with Theradiag, a pioneering European diagnostic company specialising in in vitro diagnostics and theranostics for autoimmune diseases and the monitoring of biotherapies, specifically for IBD patients. Under the agreement, Theradiag, (which is quoted on the Paris Stock Exchange on Euronext Growth - ISIN: FR0004197747, Ticker: ALTER) will have the exclusive…
Arecor Ltd, the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that it has signed a Research, Development and Commercialisation agreement with JDRF, the leading global organization funding type 1 diabetes (T1D) research.
Under this collaboration, Arecor and JDRF will contribute matching funds to develop a stable, liquid co-formulation of pramlintide and insulin (AT271) for people living with diabetes who require prandial insulin treatment. It has been demonstrated that the combined injection of pramlintide and insulin at meal-times results in…
Cambridge, UK, October 22 2019: o2h discovery is pleased to announce a significant expansion in its existing Synthetic Chemistry collaboration with Sosei Heptares, an international biopharmaceutical group focused on the design and development of new medicines originating from its proprietary GPCR-targeted StaR® technology and Structure-Based Drug Design platform capabilities.
o2h discovery supports biotechnology and pharmaceutical companies with drug discovery support from its research facility in Ahmedabad, India and is developing additional discovery biology capabilities from The Mill…
Exclusive deal with KSL Biomedical signals PredictImmune’s major move into North America
Cambridge, UK, 22 October: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today confirmed that it has entered into an exclusive commercial partnership with KSL Biomedical (KSL), to commercialise and provide PredictImmune’s prognostic test for inflammatory bowel disease (IBD), PredictSURE IBD™, throughout North America.
Under the agreement, KSL will commercialise and facilitate the fulfilment…
As well as investing and recruiting 25 graduates and school-leavers at its Cambridge office, Deloitte has also recently welcomed partner, Fran Cousins to the local Cambridge team.
Fran leads the public sector technology and digital risk business within Risk Advisory, working with healthcare, life sciences and medical devices organisations supporting their technology strategy and implementation activities. Prior to joining Deloitte in 2015, Fran worked at Cambridge University Hospitals for 18 years. She was a member of the Board of Directors for 11 years in the roles of Executive Director…
James Veale, product manager at GiroNEX – a spin-out company from Innomech Group – has been named ‘Young Design Engineer of the Year’ at the 10th anniversary British Engineering Excellence Awards ceremony in London on Friday 11 October.
James was chosen as the overall winner within his category in recognition of his technical contribution in helping GiroNEX to develop and launch its first product series at such an early point in his own career, and for his personal qualities as an ambassador for the engineering profession. James joined GiroNEX as a graduate engineer in 2017 and went on to…
Westbury, NY – Oct. 16, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired PPA Research Group, Inc., a human hematologic product provider, based in Gray, TN. This acquisition will significantly expand BioIVT’s immunology and disease-state product portfolios, enhancing its ability to support immuno-oncology and cell therapy researchers.
PPA Research Group operates full-service donor centers in Johnson City, TN and Berkeley, CA focused primarily on producing leukopaks. Leukopaks contain concentrated…